162 related articles for article (PubMed ID: 24164861)
1. Herpes simplex virus type 2 and HIV disease progression: a systematic review of observational studies.
Tan DH; Murphy K; Shah P; Walmsley SL
BMC Infect Dis; 2013 Oct; 13():502. PubMed ID: 24164861
[TBL] [Abstract][Full Text] [Related]
2. Herpes simplex virus type 2 coinfection does not accelerate CD4 count decline in untreated HIV infection.
Tan DH; Raboud JM; Kaul R; Brunetta J; Kaushic C; Kovacs C; Lee E; Luetkehoelter J; Rachlis A; Smaill F; Smieja M; Walmsley SL
Clin Infect Dis; 2013 Aug; 57(3):448-57. PubMed ID: 23572481
[TBL] [Abstract][Full Text] [Related]
3. The effect of valacyclovir on HIV and HSV-2 in HIV-infected persons on antiretroviral therapy with previously unrecognised HSV-2.
Van Wagoner N; Geisler WM; Bachmann LH; Hook EW
Int J STD AIDS; 2015 Jul; 26(8):574-81. PubMed ID: 25147236
[TBL] [Abstract][Full Text] [Related]
4. Does maternal HSV-2 coinfection increase mother-to-child transmission of HIV? A systematic review.
Sivarajah V; Venus K; Yudin MH; Murphy KE; Morrison SA; Tan DH
Sex Transm Infect; 2017 Dec; 93(8):535-542. PubMed ID: 28600331
[TBL] [Abstract][Full Text] [Related]
5. Effect of daily aciclovir on HIV disease progression in individuals in Rakai, Uganda, co-infected with HIV-1 and herpes simplex virus type 2: a randomised, double-blind placebo-controlled trial.
Reynolds SJ; Makumbi F; Newell K; Kiwanuka N; Ssebbowa P; Mondo G; Boaz I; Wawer MJ; Gray RH; Serwadda D; Quinn TC
Lancet Infect Dis; 2012 Jun; 12(6):441-8. PubMed ID: 22433279
[TBL] [Abstract][Full Text] [Related]
6. Herpes simplex virus type 2, genital ulcers and HIV-1 disease progression in postpartum women.
Roxby AC; Drake AL; John-Stewart G; Brown ER; Matemo D; Otieno PA; Farquhar C
PLoS One; 2011; 6(5):e19947. PubMed ID: 21637835
[TBL] [Abstract][Full Text] [Related]
7. Daily acyclovir for HIV-1 disease progression in people dually infected with HIV-1 and herpes simplex virus type 2: a randomised placebo-controlled trial.
Lingappa JR; Baeten JM; Wald A; Hughes JP; Thomas KK; Mujugira A; Mugo N; Bukusi EA; Cohen CR; Katabira E; Ronald A; Kiarie J; Farquhar C; Stewart GJ; Makhema J; Essex M; Were E; Fife KH; de Bruyn G; Gray GE; McIntyre JA; Manongi R; Kapiga S; Coetzee D; Allen S; Inambao M; Kayitenkore K; Karita E; Kanweka W; Delany S; Rees H; Vwalika B; Magaret AS; Wang RS; Kidoguchi L; Barnes L; Ridzon R; Corey L; Celum C;
Lancet; 2010 Mar; 375(9717):824-33. PubMed ID: 20153888
[TBL] [Abstract][Full Text] [Related]
8. Lack of association of herpes simplex virus type 2 seropositivity with the progression of HIV infection in the HERS cohort.
Hoots BE; Hudgens MG; Cole SR; King CC; Klein RS; Mayer KH; Rompalo AM; Sobel JD; Jamieson DJ; Smith JS
Am J Epidemiol; 2011 Apr; 173(7):837-44. PubMed ID: 21372062
[TBL] [Abstract][Full Text] [Related]
9. Changes in plasma human immunodeficiency virus type 1 RNA associated with herpes simplex virus reactivation and suppression.
Schacker T; Zeh J; Hu H; Shaughnessy M; Corey L
J Infect Dis; 2002 Dec; 186(12):1718-25. PubMed ID: 12447756
[TBL] [Abstract][Full Text] [Related]
10. A randomized controlled pilot trial of valacyclovir for attenuating inflammation and immune activation in HIV/herpes simplex virus 2-coinfected adults on suppressive antiretroviral therapy.
Yi TJ; Walmsley S; Szadkowski L; Raboud J; Rajwans N; Shannon B; Kumar S; Kain KC; Kaul R; Tan DH
Clin Infect Dis; 2013 Nov; 57(9):1331-8. PubMed ID: 23946220
[TBL] [Abstract][Full Text] [Related]
11. Chronic herpes simplex virus type-2 infection and HIV viral load.
Duffus WA; Mermin J; Bunnell R; Byers RH; Odongo G; Ekwaru P; Downing R
Int J STD AIDS; 2005 Nov; 16(11):733-5. PubMed ID: 16303067
[TBL] [Abstract][Full Text] [Related]
12. Acyclovir and transmission of HIV-1 from persons infected with HIV-1 and HSV-2.
Celum C; Wald A; Lingappa JR; Magaret AS; Wang RS; Mugo N; Mujugira A; Baeten JM; Mullins JI; Hughes JP; Bukusi EA; Cohen CR; Katabira E; Ronald A; Kiarie J; Farquhar C; Stewart GJ; Makhema J; Essex M; Were E; Fife KH; de Bruyn G; Gray GE; McIntyre JA; Manongi R; Kapiga S; Coetzee D; Allen S; Inambao M; Kayitenkore K; Karita E; Kanweka W; Delany S; Rees H; Vwalika B; Stevens W; Campbell MS; Thomas KK; Coombs RW; Morrow R; Whittington WL; McElrath MJ; Barnes L; Ridzon R; Corey L;
N Engl J Med; 2010 Feb; 362(5):427-39. PubMed ID: 20089951
[TBL] [Abstract][Full Text] [Related]
13. Increase in HSV shedding at initiation of antiretroviral therapy and decrease in shedding over time on antiretroviral therapy in HIV and HSV-2 infected persons.
Ford ES; Magaret AS; Spak CW; Selke S; Kuntz S; Corey L; Wald A
AIDS; 2018 Nov; 32(17):2525-2531. PubMed ID: 30289810
[TBL] [Abstract][Full Text] [Related]
14. HSV suppression reduces seminal HIV-1 levels in HIV-1/HSV-2 co-infected men who have sex with men.
Zuckerman RA; Lucchetti A; Whittington WL; Sánchez J; Coombs RW; Magaret A; Wald A; Corey L; Celum C
AIDS; 2009 Feb; 23(4):479-83. PubMed ID: 19169140
[TBL] [Abstract][Full Text] [Related]
15. Herpes Simplex Virus Suppressive Therapy in Herpes Simplex Virus-2/Human Immunodeficiency Virus-1 Coinfected Women Is Associated With Reduced Systemic CXCL10 But Not Genital Cytokines.
Andersen-Nissen E; Chang JT; Thomas KK; Adams D; Celum C; Sanchez J; Coombs RW; McElrath MJ; Baeten JM
Sex Transm Dis; 2016 Dec; 43(12):761-764. PubMed ID: 27832025
[TBL] [Abstract][Full Text] [Related]
16. Recalcitrant pseudotumoral anogenital herpes simplex virus type 2 in HIV-infected patients: evidence for predominant B-lymphoplasmocytic infiltration and immunomodulators as effective therapeutic strategy.
Sbidian E; Battistella M; Legoff J; Lafaurie M; Bézier M; Agbalika F; Simon F; Bouscarat F; Cayuela JM; Carcelain G; Houhou N; Bagot M; Molina JM; Janier M; Bachelez H
Clin Infect Dis; 2013 Dec; 57(11):1648-55. PubMed ID: 24065320
[TBL] [Abstract][Full Text] [Related]
17. A randomised placebo-controlled trial to explore the effect of suppressive therapy with acyclovir on genital shedding of HIV-1 and herpes simplex virus type 2 among Zimbabwean sex workers.
Cowan FM; Pascoe SJ; Barlow KL; Langhaug LF; Jaffar S; Hargrove JW; Robinson NJ; Bassett MT; Wilson D; Brown DW; Hayes RJ
Sex Transm Infect; 2008 Dec; 84(7):548-53. PubMed ID: 18684855
[TBL] [Abstract][Full Text] [Related]
18. Effects of HIV-1 and herpes simplex virus type 2 infection on lymphocyte and dendritic cell density in adult foreskins from Rakai, Uganda.
Johnson KE; Redd AD; Quinn TC; Collinson-Streng AN; Cornish T; Kong X; Sharma R; Tobian AA; Tsai B; Sherman ME; Kigozi G; Serwadda D; Wawer MJ; Gray RH
J Infect Dis; 2011 Mar; 203(5):602-9. PubMed ID: 21220779
[TBL] [Abstract][Full Text] [Related]
19. Association between HSV-2 and HIV-1 viral load in semen, cervico-vaginal secretions and genital ulcers of Thai men and women.
Chu K; Jiamton S; Pepin J; Cowan F; Mahakkanukrauh B; Suttent R; Robinson NJ; Deslandes S; Frost E; Chaisilwattana P; Suthipinittharm P; Grosskurth H; Brown D; Jaffar S
Int J STD AIDS; 2006 Oct; 17(10):681-6. PubMed ID: 17059638
[TBL] [Abstract][Full Text] [Related]
20. Human immunodeficiency virus-1 infection correlates strongly with herpes simplex virus-2 (genital herpes) seropositivity in South African and United States blood donations.
Benjamin RJ; Busch MP; Fang CT; Notari EP; Puren A; Schoub BD; Tobler LH; Hogrefe W; du P Heyns A; Stramer SL; Crookes RL
Transfusion; 2008 Feb; 48(2):295-303. PubMed ID: 18005322
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
